Cipla had received regulatory approval from the Central Drugs Standard Control Organisation late last year for the exclusive distribution and marketing of Afrezza.
Cipla had received regulatory approval from the Central Drugs Standard Control Organisation late last year for the exclusive distribution and marketing of Afrezza.